CAMPBELL, Calif. , Oct. 14, 2022 /PRNewswire/ -- Body Vision Medical, a leader in AI-driven, intraoperative imaging, today announces it is expanding AI Tomography, its latest generation of real-time imaging technology that produces intraoperative CT scans in axial, coronal, and sagittal planes, to GE's line of OEC C-arms.
"Body Vision's approach with LungVision is to ensure that it agnostically works with as broad a base of existing imaging and bronchoscopy equipment as possible so that as many medical institutions and the lung patients they serve can benefit from access to advanced real-time, intraoperative imaging," said David Webster , CEO of Body Vision Medical. "This holds true for AI Tomography, our latest generation of intraoperative imaging technology which we first released for Siemens C-arms but are now expanding to GE's line of C-arms."
Body Vision Medical's LungVision™ system uses artificial intelligence (AI) to transform X-ray images from any C-arm into real-time, intraoperative 3D scans. AI Tomography takes this one step further by significantly enhancing image quality and rendering the CT scans in the traditional axial, coronal and sagittal planes familiar to clinicians. LungVision empowers bronchoscopists to biopsy from smaller, more difficult-to-access lung lesions at an earlier stage, thus maximizing the likelihood of an early diagnosis for lung cancer patients and improving odds for survival.
Body Vision will be offering demonstrations of its LungVision™ system at the upcoming American College of Chest Physicians (CHEST) Annual Meeting taking place in Nashville, TN from October 17-19, 2022 .
To learn more about Body Vision Medical, visit bodyvisionmedical.com.
Body Vision Medical specializes in AI-driven, intraoperative imaging with the aim of saving lives through the democratization of innovative medical technology. Its first commercial product, LungVision™, addresses the unmet clinical need for early, definitive lung cancer diagnosis and, in the future, to enable effective treatment of lung lesions via a minimally-invasive procedure. Visit bodyvisionmedical.com to learn more and connect with us on LinkedIn.
Contact info@bodyvisionmedical.com +1-646-863-7848
View original content to download multimedia:https://www.prnewswire.com/news-releases/body-vision-medical-announces-ai-tomography-intraoperative-ct-imaging-for-ges-oec-line-of-c-arms-301649895.html
The CDC said BQ.1 and one of its descendants, BQ.1.1, represent "a small but fast-growing subset of the Omicron variant."
Pfizer, BioNTech, Moderna, Merck and GSK are included in this Analyst Blog.
A new subvariant of the omicron variant of the coronavirus is becoming increasingly prevalent in the United States, according to data from the Centers for Disease Control and Prevention (CDC). CDC data shows that the BQ.1 and BQ.1.1 variants each made up 5.7 percent of the total number of cases in the country in the…
Two new offshoots that experts say appear to spread easily were estimated to represent 11.4% of U.S. cases by mid-October, according to the CDC.
Relmada's (RLMD) phase III study, evaluating REL-1017 in major depressive disorder, fails to achieve statistical significance. Shares plunge 80% following the news.
The minimum treatment for a snake bite is 10 vials of antivenom and the cost of each vial is in the four digits.
Nevro (NVRO) gets FDA approval for its next-generation SCS system, Senza HFX iQ, for treating chronic back and leg pain.
A faster pace showed positive outcomes for heart disease, cancer, dementia and death, over and above the total number of daily steps taken
As a new study confirms drinking too much really does make you look older, Lisa Salmon looks into other lifestyle factors that may contribute too
Materials known as metal-organic frameworks hold promise for advances in healthcare, energy and other areas, researchers say.
Ahead of Audacy's We Can Survive concert in support of suicide prevention, the always-candid frontwoman discusses mental health awareness and why she has "always believed in the destruction of taboos."
Relmada stock crashed Thursday after its depression treatment failed a final-phase test, helping bolster rival Axsome. AXSM stock surged.
It has become pretty much impossible to keep up with all of the latest coronavirus variants, but there's most likely a new wave on the way.
Tom Arruda runs and plays golf to stay fit. After an August 2020 checkup, doctors gave the then 48-year-old father of two a clean bill of health. But just three months later, the Henrico man's health took a turn. In November 2020, he started tasting blood.
Doctors are promoting trans “top surgery” on social media, it has emerged amid concerns about the impact on young people.
Patients should work with their health care professionals to determine their best treatment option until supply is restored.
It wasn’t so long ago that any COVID variant that hit the U.K. was headed to the U.S. in short order. But now the variant—or swarm of variants—to next plague North America is anyone’s best guess.
This health stock is up over 9% for the week and within 3% of a buy point on the chart. Shares soared on news of its obesity treatment.
Pfizer released its first human data results on the bivalent omicron booster, which showed an increase in antibodies, but more data is needed to show how effective the shot is.
Emma Tuck became ill “out of the blue” three years ago.